Medi Assist Healthcare Services Limited
₹296.75-₹1.65 (-0.6%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹3,312 Cr
- P/E
- 82.7x
- EV / EBITDA
- 89.0x
- Revenue
- ₹151 Cr
- Net margin
- 17.6%
- ROCE
- 17.5%
Price chart
Technical chartScreen technicals →-47.7% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -1.9%
- 3M
- -17.0%
- 6M
- -14.0%
- 1Y
- -47.7%
- 5Y
- -36.2%
52-week range
Day change -₹1.65 (-0.6%) from ₹298 to ₹297 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in MEDIASSIST, bought on each weekday since 2024.
AI Summary
Indian StockStrengths1
- Maintains healthy dividend payout of 90.0%
Concerns1
- Low return on equity of 8.8%
Rule-based from financial data. Not advice.
About the company
Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third party administration services in India and internationally. The company offers business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector. It also provides; and policy administration services to governments to enable public health schemes. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
- Sector
- Healthcare
- Shares outstanding
- 7.5 Cr shares
- ISIN
- INE456Z01021
- BSE code
- 544088
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹3,312 Cr
- P/E
- 82.7x
- P/B
- 12.0x
- EV / EBITDA
- 89.0x
- EV / Sales
- 30.5x
- P/S
- 30.7x
- Earnings yield
- 1.2%
- 52-week high
- ₹571.60
- 52-week low
- ₹282.15
Profitability
- Operating margin
- 35.2%
- Net margin
- 17.6%
- EBITDA margin
- 34.3%
- ROE
- 8.8%
- ROCE
- 17.5%
- ROA
- 7.5%
- Dividend payout
- 90.0%
- Tax rate
- 24.0%
- Other income, % of PBT
- -3.8%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹151 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 39.8%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 11.7%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹37.0 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 48.0%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 73.7%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -12.5%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹40.0 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 66.7%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹2.00 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 27.3%
Solvency and efficiency
- Current ratio
- 6.63
- Debt / Equity
- 0.00
- Debt / Assets
- 0.00
- Debt / EBITDA
- 0.03
- Financial leverage
- 1.17
- CFO / Net profit
- 2.11
- Cash / Market cap
- 3.0%
- Cash per share
- ₹13.27
- Asset turnover
- 0.43
- Fixed asset turnover
- 6.35
- Capital intensity
- 0.16
- Debtor days
- 52 days
- Cash conversion cycle
- 52 days
Where the revenue went
Some FY2025 lines are not reported, so the ones that are appear as a table.
| Line | FY2025 |
|---|---|
| Sales | ₹151 Cr |
| Expenses | ₹91 Cr |
| Operating profit | ₹59 Cr |
| Other income | ₹8 Cr |
| Interest | ₹4 Cr |
| Depreciation | ₹19 Cr |
| Profit before tax | ₹45 Cr |
| Tax and other | ₹12 Cr |
| Net profit | ₹33 Cr |
Revenue and net profit
Revenue grew 39.8% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹54 Cr | ₹35 Cr |
| FY2022 | ₹55 Cr | ₹18 Cr |
| FY2023 | ₹64 Cr | ₹17 Cr |
| FY2024 | ₹108 Cr | ₹19 Cr |
| FY2025 | ₹151 Cr | ₹33 Cr |
Cash flows
FY2025: ₹63.0 Cr from operations, ₹14.0 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹24 Cr | ₹52 Cr |
| FY2022 | -₹8 Cr | -₹12 Cr |
| FY2023 | ₹24 Cr | ₹31 Cr |
| FY2024 | ₹40 Cr | -₹9 Cr |
| FY2025 | ₹63 Cr | ₹14 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹151 Cr+39.8%1Y
- Net profit
- ₹33 Cr+73.7%1Y
- Cash from operations
- ₹63 Cr
- Free cash flow
- ₹14 Cr
- Revenue CAGR, 5Y
- 11.7%
- EBITDA CAGR, 5Y
- -9.2%
- Net profit CAGR, 5Y
- -12.5%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹151 Cr | ₹59 Cr | — | ₹33 Cr | ₹63 Cr | ₹14 Cr | 14.4% | +39.8% | +73.7% |
Monthly returns
Month-by-month returns of MEDIASSIST across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹331 Cr |
| Equity capital | ₹35 Cr |
| Reserves | ₹194 Cr |
| Borrowings | ₹15 Cr |
| Other liabilities | ₹86 Cr |
| Assets | ₹331 Cr |
| Fixed assets | ₹64 Cr |
| Capital work in progress | ₹4 Cr |
| Investments | ₹120 Cr |
| Other assets | ₹143 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
MEDIASSIST trades at 82.7x earnings against a peer median of 52.6x (a 57% premium).
Not shown (no positive earnings and no EV / Sales): Suven Life Sciences Ltd.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Medi Assist Healthcare Services LimitedMEDIASSISTthis companyP/E ↑ premium | ₹3,312 Cr | 82.7x | 12.0x | 8.8% | 89.0x |
| INNOVA CAPTAB LIMITEDINNOVACAP | ₹3,945 Cr | 51.8x | 4.6x | 9.4% | 34.2x |
| RPG Life Sciences LimitedRPGLIFE | ₹3,806 Cr | 34.2x | 6.9x | 23.5% | 27.7x |
| SENORES PHARMACEUTICALS LIMITEDSENORES | ₹3,750 Cr | 307.0x | 5.2x | 0.6% | 545.5x |
| Indraprastha Medical Corporation LtINDRAMEDCO | ₹3,742 Cr | 21.4x | 5.7x | 25.9% | 17.5x |
| Orchid Pharma LimitedORCHPHARMA | ₹3,739 Cr | 51.8x | 2.8x | — | — |
| Suven Life Sciences Ltd.SUVEN | ₹3,490 Cr | — | 3.3x | -0.9% | -1728.5x |
| Gufic BioSciences Ltd.GUFICBIO | ₹3,200 Cr | 58.9x | 5.1x | 16.1% | 22.7x |
| Unichem Laboratories Ltd.UNICHEMLAB | ₹2,905 Cr | 34.6x | 1.2x | -4.0% | 111.4x |
| Peer median | — | 52.6x | 5.9x | 12.1% | 38.3x |
Year-to-date ROI
MEDIASSIST since 1 January, against earlier years.
Historical volatility
MEDIASSIST's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 22.0% |
| FY2022 | 25.0% |
| FY2023 | 5.0% |
| FY2024 | 35.0% |
| FY2025 | 39.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹151 Cr |
| Costs | |
| Interest | ₹4 Cr |
| Expenses | ₹91 Cr |
| Operating profitOperating Profit | ₹59 Cr |
| Other income and charges | |
| Profit before tax | ₹45 Cr |
| Tax | |
| Net profitNet Profit | ₹33 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹331 Cr |
| Equity capitalEquity Capital | ₹35 Cr |
| Reserves | ₹194 Cr |
| Borrowings | ₹15 Cr |
| Other liabilitiesOther Liabilities | ₹86 Cr |
| AssetsTotal Assets | ₹331 Cr |
| Fixed assetsFixed Assets | ₹64 Cr |
| Capital work in progressCWIP | ₹4 Cr |
| Investments | ₹120 Cr |
| Other assetsOther Assets | ₹143 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹63 Cr |
| Investing cash flowCash from Investing Activity | -₹49 Cr |
| Financing cash flowCash from Financing Activity | -₹12 Cr |
| Change in cashNet Cash Flow | ₹2 Cr |
Learn while you research
Academy chapters picked for Medi Assist Healthcare Services Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 82.7, learn when high multiples are justified.6 min read
- 04 Growth Investing40% revenue growth is in the top tier, learn how to value growth.7 min read
- 05 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 06 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read